Advertisement

Topics

Verastem Oncology Company Profile

10:29 EST 23rd January 2019 | BioPortfolio

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Verastem Oncology is currently developing duvelisib, a dual inhibitor of PI3K-delta and PI3K-gamma, which has successfully met its primary endpoint in a Phase 2 study in indolent Non-Hodgkin Lymphoma (iNHL) and a Phase 3 clinical trial in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Verastem Oncology’s New Drug Application (NDA) requesting the full approval of duvelisib for the treatment of patients with relapsed or refractory CLL/SLL, and accelerated approval for the treatment of patients with relapsed or refractory follicular lymphoma (FL) was accepted for filing by the U.S. Food and Drug Administration (FDA), granted Priority Review and assigned a target action date of October 5, 2018. In addition, Verastem Oncology is developing the FAK inhibitor defactinib, which is currently being evaluated in three separate clinical collaborations in combination with immunotherapeutic agents for the treatment of several different cancer types, including pancreatic cancer, ovarian cancer, non-small-cell lung cancer (NSCLC), and mesothelioma. Verastem Oncology’s product candidates seek to treat cancer by modulating the local tumor microenvironment and enhancing anti-tumor immunity. For more information, please visit www.verastem.com.


News Articles [538 Associated News Articles listed on BioPortfolio]

Verastem Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients...

Verastem Oncology to Present at Upcoming Investor Conferences

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients...

Verastem's lymphoma drug gets FDA accelerated approval

The FDA granted accelerated approval for Verastem Oncology's Copiktra, or duvelisib, as a treatment for adult patients with s -More- 

US clears Verastem’s Copiktra for blood cancers

Verastem Oncology’s Copiktra has been approved in the US for the treatment relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma after at least two prior therapies.

Catalent and Verastem Partner on Newly Launched Cancer Treatment

NewsCatalent has a multi-year collaboration with Verastem Oncology, providing clinical development, analytical support, and manufacturing services.

FDA Approves Verastem’s Copiktra for Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of c...

US FDA approves Catalent’s collaborative oncology treatment

Oncology drug Copiktra was developed during a multi-year collaboration between Catalent Pharma and Verastem Oncology.

FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma

BOSTON--(BUSINESS WIRE)--Sep. 24, 2018-- Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of lif...

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Copiktra [Verastem, Inc.]

These highlights do not include all the information needed to use COPIKTRA safely and effectively. See full prescribing information for COPIKTRA. COPIKTRA (duvelisib), capsules for oral use Initial U....

Rubraca [Clovis Oncology, Inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. App...

Carboplatin [Sagent Pharmaceuticals]

Carboplatin Injection(carboplatin aqueous solution)

Carboplatin [Meitheal Pharmaceuticals Inc.]

Carboplatin Injection(carboplatin aqueous solution)

PubMed Articles [1234 Associated PubMed Articles listed on BioPortfolio]

"Neuro-oncology research in Nigeria: a great untapped potential".

Nigeria has the largest population in Africa and has sub-optimal access to neuro-oncology care. It has been estimated that there is approximately 1 neurosurgeon to 2.4 million people in the country, w...

Share of Oncology Versus Nononcology Spending in Episodes Defined by the Centers for Medicare & Medicaid Services Oncology Care Model.

Performance-based payments to oncology providers participating in the Centers for Medicare & Medicaid Services (CMS) Oncology Care Model (OCM) are based, in part, on overall spending in 6-month episod...

Burnout and Resiliency in Canadian Oncology Residents: a Nationwide Resident and Program Director Survey.

To measure burnout rates and resiliency scores in Canadian Oncology residents and to advance the knowledge regarding resiliency and wellness training in Canadian Oncology residency programs.

Development of a Virtual Radiation Oncology Clinic for training and simulation of errors in the radiation oncology workflow.

Integrative Oncology Scholars Program: A Model for Integrative Oncology Education.

Oncology providers are often confronted by patients who use complementary or alternative therapies, but have limited knowledge or confidence on how to advise patients on appropriate use. Despite this,...

Clinical Trials [579 Associated Clinical Trials listed on BioPortfolio]

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Osteopathic Manipulative Treatment in Oncology Patients' Management

The aim of present study was to study the osteopathic manipulative effects on pain relief and quality of life improvement on hospitalized oncology geriatric patients. A non-randomized comp...

Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa

The ultimate aim of this registry is to collect precise information concerning the children coming to oncology units working with the French African Oncology Group. This data will help to ...

Companies [752 Associated Companies listed on BioPortfolio]

Verastem Oncology

Verastem, Inc. (Nasdaq:VSTM), operating as Verastem Oncology, is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and qualit...

Verastem, Inc. Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor ...

Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cell...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

OncLive

OncLive is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary O...

More Information about "Verastem Oncology" on BioPortfolio

We have published hundreds of Verastem Oncology news stories on BioPortfolio along with dozens of Verastem Oncology Clinical Trials and PubMed Articles about Verastem Oncology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Verastem Oncology Companies in our database. You can also find out about relevant Verastem Oncology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record